Cargando...

Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis

BACKGROUND: Treatment with recombinant human erythropoietin (rHuEPO) in dialysis patients has been shown to be highly effective in terms of correcting anaemia and improving quality of life. There is debate concerning the benefits of rHuEPO use in predialysis patients which may accelerate the deterio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: Cody, June D, Hodson, Elisabeth M
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2016
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7144724/
https://ncbi.nlm.nih.gov/pubmed/26790135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003266.pub3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!